Metharbital
From Wikipedia, the free encyclopedia
![]() |
|
|---|---|
| Systematic (IUPAC) name | |
| 5,5-diethyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione | |
| Clinical data | |
| AHFS/Drugs.com | monograph |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 50-11-3 |
| ATC code | N03AA30 |
| PubChem | CID 4099 |
| DrugBank | APRD00757 |
| ChemSpider | 3957 |
| UNII | 02OS7K758T |
| KEGG | D01382 |
| ChEMBL | CHEMBL450 |
| Chemical data | |
| Formula | C9H14N2O3 |
| Mol. mass | 198.219 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Metharbital was patented in 1905 by Emil Fischer working for Merck.[1] It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy. It has similar properties to phenobarbital.
[edit] History
- 1952 Gemonil was introduced by Abbott Laboratories.
- 1990 Abbott stopped marketing.
[edit] Chemistry
Metharbital (5,5-diethyl-1-methylbarbituric acid) is synthesized by condensation of diethylmalonic ester with methylurea.
- A. Halpern, J.W. Jones, J. Am. Pharm. Assoc., 38, 352 (1949).
- Snyder, J. A.; Link, K. P. (1953). Journal of the American Chemical Society 75 (8): 1881. doi:10.1021/ja01104a030.
[edit] References
- The Treatment of Epilepsy 2nd Ed by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. ISBN 0-632-06046-8
- The Medical Treatment of Epilepsy by Stanley R Resor. Published by Marcel Dekker (1991). ISBN 0-8247-8549-5.
- The Comparative Toxicogenomics Database: Metharbital
- ^ US Patent 782742
| This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it. |
